Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Exemestane
Medication labelAROMASIN is indicated for adjuvant treatment of postmenopausal women with estrogen-receptor positive early breast cancer who have received…
Why this: Advisory · dailymed-prescription
AROMASIN is indicated for adjuvant treatment of postmenopausal women with estrogen-receptor positive early breast cancer who have received two to three years of tamoxifen and are switched to AROMASIN for completion of a total of five consecutive years of adjuvant hormonal therapy. AROMASIN is indicated for the treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy.
- generic_name
- exemestane
- product_names
- exemestane
- ndc
- 54868-5261, 0009-7663, 54868-5261-0
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en